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Why We Do What We Do…
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Recent SANS Headlines:
Page No. 4
 Bottom-line: Not human friendly. For example…
• Vacuum: No atmosphere; no air
• Gravity
 Gravity reduces w/ distance. ISS (@ ~200-250 mi) feels 90% of 
Earth’s gravity…But…
 ISS moves at ~17,500 mph, in constant freefall = “Microgravity”
• Temperature extremes
• Ionizing (high energy) radiation: Galactic cosmic rays, 
solar proton events
• Orbiting space junk/debris: >550K larger than 1cm
• Spaceflight Associated Neuro-ocular Syndrome (SANS)
 Formerly called Visual Impairment Intracranial Pressure (VIIP)
 A top risk to Deep Space Journey (e.g., mission to Mars)
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 International Space Station (ISS)
• In use since 2000
 51 expeditions completed
• *n = 58 (as of 31Jan17)
• Duration: ~0.5 to 1y
• International partners
 United States
 Russia
 European Union
 Canada
 Japan
• Crew: Typically 5-6
• “Low Earth orbit”
* Person flights; may include multiple-time flyers w/in program
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• NASA to send humans to: An asteroid by 2025; Mars in the 2030s
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 Ocular testing has been performed pre- & post-flight
 Initial eye/vision testing capability on ISS was…
• Ophthalmoscope (astro-physicians only)
• Paper VA chart
• Amsler grid
 Sentinel SANS case discovered in 2005, post-flight
• Optic disc edema & cotton wool spot
 Surveillance/medical data collection has evolved
• Some SANS-related testing began in 2008 (w/ Exp 18), but inconsistent
• Feb 2010 (Exp 23): Standardized medical monitoring (i.e., “Eye MED B”) 
established
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Ocular Surveillance
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Ocular Surveillance
Terrestrially
 3T MRI – Special “NASA Astronaut” protocol
 Visual Field (Threshold) Perimetry
 Cycloplegic Refraction
Terrestrially & On-Orbit
 Vision Exam
• Distance visual acuity (ISS: Acuity Pro on laptop)
• Near visual acuity (ISS: Handheld card)
• Amsler grid (ISS: Laptop)
 Ocular Ultrasound
 Tonometry (when clinically indicated)
 Fundoscopy
 Optical Coherence Tomography (OCT)
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Clinical Findings
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Pre-flight fundoscopic images of 
the optic discs 
Post-flight images of optic discs, 
showing Grade 3 edema OD & 
Grade 1 edema OS  
OD                                 OS
OD                               OS
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Fundoscopic image of optic disc OD, 
10 days after return to Earth
• Arrows: “C” shaped halo of edema
 Terrestrially: Optic disc edema is associated with:
• Unilateral: Optic neuritis, optic neuropathy, retinal 
artery/vein occlusion
• Bilateral: Increase in ICP…
 IIH ( “papilledema”)
 Intracranial mass
 Obstructive hydrocephalus
 Cerebral edema
 Increased CSF production
 Decreased CSF absorption
 Venous outflow obstruction 
• Typically reduces VA, enlarges blind spot, causes 
relative afferent pupillary defect & color impairment  
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Post-flight ultrasound image of globe, optic 
nerve (ON; purple), and optic nerve sheath 
(green). Showing:
• ON Sheath distention
• ON tortuosity 
 ON Sheath terrestrially:
• Normal diameter (ONSD) < 5.9 mm
• Enlargement typically associated w/ 
increased ICP
12 mm
In-Flight OD
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Post-flight OD
Pre-flight OD
Choroid
Retina
Fovea
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OD                          Post-flight                           OS
Pre-flight OD                          Post-flight OD
 Choroidal thickening due to vessel 
engorgement  induces choroidal 
(and sometimes retinal) folds
 Usually run horizontally (not 
concentrically around ONH)
 Can resolve post-flight or can 
persist (for 5+ yrs)
 So far, no clinically-significant 
impact on BCVA
 Terrestrially: Assoc. w/ choroidal 
tumors, scleritis, retrobulbar mass, 
papilledema/IIH
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Surveillance & Medical Data Collection
Post-flight OCT “circle scans” showing RNFL 
thickening consistent w/ observed optic disc edema OU
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 Case Example:
ssociated w/ papilledema
(i.e., disc edema 2o to increased 
intracranial pressure); typically bilateral Pre-flight
MRI
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6 days post-flight
MRI
 Case Example:
ssociated w/ papilledema
(i.e., disc edema 2o to increased 
intracranial pressure); typically bilateral 
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1 year post-flight
MRI
 Case Example:
ssociated w/ papilledema
(i.e., disc edema 2o to increased 
intracranial pressure); typically bilateral 
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Pre-flight
MRI
 Case Example:
ssociated w/ papilledema
(i.e., disc edema 2o to increased 
intracranial pressure); typically bilateral 
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 Of the active astronaut population…
• 80% wear vision correction (32% contact lenses)
• Mean age = 47 yrs
• Majority are presbyopic (i.e., a normal, age-related, progressively worsening inability to 
focus clearly on near objects) 
 Post-flight questionnaires (1989 - 2011): 29% of short- & 60% of long-duration 
mission astronauts report a subjective degradation in vision, especially at near
• Provided “Space Anticipation Glasses”
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Why is this Happening?
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 Terrestrially  Fluid is pulled downward by 
gravity (i.e., hydrostatic pressure) 
 Microgravity  Fluid is free to uniformly 
distribute (i.e., hydrostatic pressure is eliminated)
Why is this Happening?
Consider how hydrostatic 
pressure affects fluid/blood 
distribution in humans… 
And what happens in its 
absence… 
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Why is this Happening?
Microgravity  Cephalad fluid shift  Cerebral venous congestion (i.e., overfilling & distension)
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Microgravity  Cephalad fluid shift  Cerebral venous congestion (i.e., overfilling & distension)
Why is this Happening?
 Hypothesis #1: Increased intracranial pressure (ICP) 
• e.g., Enough to cause an imbalance between ICP & 
intraocular pressure (i.e., translaminar pressure gradient)
 Hypothesis #2: A local eye problem
• e.g., Compartmentalization of perioptic subarchnoid
spaces
 Hypothesis #3: Individual anatomical/genetic factors
• e.g., Altered folate-dependent 1-carbon metabolism
 Hypothesis #4: Venous congestion alters local 
physiology and/or places direct pressure on retinal 
axons
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In-flight Exacerbating Factors??
Resistive Exercise
High Oral Sodium Intake
Prepackaged Foods…
Up to 5000+ mg/day
In-flight  Pharmaceuticals
High CO2
~10x terrestrial levels
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Common Characteristics of the Cases
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 Almost all were “long duration” (i.e., >30 day) ISS mission crewmembers
• One short-duration case w/ subtle disc edema (discovered retrospectively)
• Severity related to flight duration?? [So…what about a 3-yr Mars mission??] 
 Normal past medical history:
• Negative for uncontrolled systemic disease
• None used medications before/during mission that would increase ICP 
(e.g., vitamin A, tetracycline, corticosteroids, or nalidixic acid)
 ISS cabin 
• Normal pressure & oxygen
• Elevated CO2 
 ~0.33-0.5% avg, w/ avg peak ~0.7%; 10x terrestrially: ~0.03-0.04%
Common Characteristics of the Cases
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 All had normal pre-flight eye exams
 None experienced loss in BCVA, color vision, or stereopsis
 None complained of severe headaches, transient vision obscurations, 
double vision, pulsatile tinnitus, or vision changes during eye movements 
(i.e., classic symptoms of idiopathic intracranial hypertension)
 OD affected more than OS in all cases. If monocular, always OD
 For 14 crewmembers having complete pre-flight & on-orbit OCT data, 
regardless of SANS diagnosis, ALL show signs of:
• Choroidal engorgement, Optic disc edema (subclinical or clinical), extending 
into the retinal nerve fiber layer; Retinal venous engorgement
Common Characteristics of the Cases
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Clinical & Research Update
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Ongoing SANS Efforts: Clinical/Research
Clinical
 “Form & Function”: Are there any RNFL 
thickness losses (via OCT)? If so, are there 
correlations w/ any reduction in visual 
sensitivity (via visual field)?
• KEY Concern/Risk: Potential impact of 
disc/retinal edema during longer duration 
missions (>>12 months)
 Deploy next-generation OCT: 
• Faster (~60%); better signal-to-noise; MultiColor 
imaging
 Consider deploying an ISS visual field device
 Consider possibility of venous congestion as a 
SANS contributing factor
Research
 Ocular Health Study & Fluid Shifts Study 
 Clinical relevance of MRI-based findings
 Implementation of direct ICP measures 
(Lumbar puncture pre- & post-mission)
 Correlation btwn SANS & CO2 using HDT 
(EnviHab)
Source: Mayra 
Nelman & Simon 
Clemett, PhD
ONH Surface Topography
* Indicates 
Case
Source: Mayra 
Nelman & Simon 
Clemett, PhD
Subject 2 Subject 3* Subject 4*
Subject 5* Subject 6* Subject 7* Subject 8
Subject 1*
Subject 9 Subject 10
Subject 11 Subject 12
Lamina Cribrosa Movement
Source: Mayra 
Nelman & Simon 
Clemett, PhD Subject 5*
* Indicates 
Case
Subject 8
Page No. 44
Questions?
CAPT Tyson Brunstetter, MSC (AsO), USN
COM: 281-792-7705
Email: Tyson.J.Brunstetter@nasa.gov
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